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Medical Surveillance of Exposed Persons
After Exposure to PCBs, Chlorinated
Dibenzodioxins and Dibenzofurans after
PCB Transformer or Capacitor Incidents
by Arnold Schecter*
The panel discussion from the perspective of occupational medicine regarding appropriate medical
surveillance after a PCB transformer or capacitor incident is reviewed. A thorough occupational medicine
history and physical examination is stressed for any worker or other patient who may have been exposed.
Appropriate laboratory tests, including complete blood count with differential, serum chemistries, serial
bloodPCBdeterminiations, fatbiopsytoestimate furan anddioxin levels, ifindicated, pulmonaryfunction
tests, chest X-rays, urinalysis including porphyrin measurement, nerve conduction velocity testing and
other tests are discussed. No consensus was reached on recommended length of medical followup.
Because the field is rapidly changing, yearly updates of medical protocols are warranted. In addition,
the need for surveillance to be conducted by specialists with training and experience in the fields of
occupational medicine and nursing was emphasized. It was stressed that measuring the chemicals and
their levels in soot and air and then comparing these with the patient's blood or fat levels, in the case of
PCBs, furans and dioxins, is vital. It was noted that at present no modality of treatment is known to be
clinically efficacious in removing PCBs, furans and dioxins from tissues or blood.
Introduction
The occupational medicine physician is faced with a
dilemmaafterPCB, dioxinorfuranandchlorinatedben-
zene incidents (1,2). Frequently no baseline data is
available for exposed workers. Next, there are few if
anytoxicological dataonthe various isomers whichmay
exist in the soot or air for animals let alone humans.
There are no standard assays yet for determining or
estimating exposure. Certainly, based on animal data
and limited but growing human data there is no stan-
dard approach which is accepted by most experts in the
field.
However, based on animal toxicological data from
multiplespecies, humandatafromvariousPCB exposed
workers, and data from a number ofincidents, the Yu-
sho and Yu Cheng PCB/furan incidents in the Orient,
the Seveso, Italy, dioxin incident, and the Nitro, West
Virginia Monsanto dioxin incident as well as the more
recent Binghamton State Office Building (BSOB) inci-
dent it seems reasonable to consider the following ap-
proach based on the limited medical data available at
this time.
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Laboratory Data
First, one would wish to immediately draw a fasting
blood sample from the patient as soon afterthe incident
as possible to attempt to obtain baseline data. In ad-
dition, urine specimens for routine urinalysis as well as
possibly for urine porphyrin levels and patterns should
be obtained. Blood samples forhemoglobin, hematocrit,
white and red cell counts as well as differential and
platelet count should be performed. The usual blood
chemistries, especially all liver tests, such as SGOT,
SGPT, gamma GTP, alkaline phosphatase, direct and
indirect bilirubin, and serum cholesterol and triglyc-
eride levels, as well as albumin and globulin levels should
be obtained. Several samples of serum, not drawn in
plastic syringes or containers should be frozen for pos-
sible future PCB levels and pattern analysis. Blood, 10
to 100 mL, should also be drawn and frozen forpossible
future dioxin and furan analysis. Urinary glucaric acid
and urinary 6-b-hydroxycortisol as indicators ofmicro-
somalenzyme inductionmayalsobeuseful; forthe same
reason, some authors recommend the aminopyrene
breath test (3-6).
Examination oflymphocytes for immune competance
is not usually performed, although Bekesi (7) at Mt.
Sinai in New York and Carnow (8) in Chicago have
reported immune deficiency in humans after exposureA. SCHECTER
to dioxins (along with other chemical contaminants).
Carnow and associates also perform sperm analysis,
having found sperm abnormalities in a number of pa-
tients, after one incident.
Thymus and bone marrow may be of interest, espe-
cially inthe young. Bone marrow activity is customarily
monitored by hematological screening, although bone
marrow aspiration might be indicated or at least not
contraindicated were there to be abnormal findings. In
a similar fashion, based on the findings of Hay (9) that
2,3,7,8-TCDD is mutagenic in at least one cell system
and considering that these compounds may well be pro-
moters if not inducers of cancer in humans, leading to
chromosomal alterations, it may be reasonable to con-
sider peripheral lymphocyte chromosome studies as a
possible biological marker. This appears not yet to have
been systematically studied carefully by experts in the
field after such chemical exposure in humans.
Parenthetically, because of multimillion dollar legal
verdicts after exposure to dioxin and other chemicals,
it may prove better to perform unusual and costly tests
for legal as well as medical reasons sequentially during
the first few months after exposure to detect patholog-
ical changes which might arise from the incident-or to
rule out such changes.
Radiographic studies oflungs seems indicated to es-
tablish a baseline, as do pulmonary function tests be-
cause of compromises in pulmonary function reported
by Warshaw and colleagues after PCB exposure (10).
From monkey data one wonders whether an upper gas-
trointestinal (GI) series might not beindicated to detect
or rule out changes in gastric mucosa. Gastroscopy might
also be appropriate, especially ifsymptoms are present
after exposure. X-rays with the use of contrast media
might be of selective interest, as might computerized
axial tomography (CAT scans) to evaluate liver or spleen.
PET scans or NMR evaluations may prove useful in
future years especially toprovide earlywarningoffunc-
tional organ change but have not thus far been utilized
in follow up of PCB or dioxin exposed patients, to the
best of our knowledge.
Fat biopsies are the only means available at present
to measure furan or dioxin levels in body tissue and are
thus, in our opinion, indicated as a biological marker to
estimate extent ofexposure. Forthe same reason, liver
ultrastructural changes have been reported in multiple
animal species as well as in man after PCB, dioxin,
chlordecone and related chlorinated aromatic com-
pounds and therefore biopsies may also be indicated as
biological markers, especially if liver pathology con-
sistent with the chemical exposure exists.
Medical History
Athoroughmedicalhistoryshould betaken, including
allpossible chemical exposures, alcohol, medication and
illicit drug use, previous illness and familial illness, al-
lergies and reproductive outcomes in family members
aswell as cancerhistory. In short, it mustbe athorough
occupational history taken by a knowledgeable and ex-
perienced occupational medicine physician.
Medical Examination
The examination of the patient should include color
photographs ofskinincludingface, shoulders, chest and
back, at least, in order to establish baselines. Photog-
raphy of the entire body is desirable. At the present
time, chloracne is rarely observed after dioxin or PCB
exposure, and its diagnosis varies from physician to
physician, with widelydifferingcriteriabeingused (11-
13). Any acne appearing in an adult who did not have
acne before exposure to a chloracne producing com-
pound is, by definition, chloracne, in the judgment of
somephysicians. Othersmayrequireagroupofworkers
to develop skin lesions after exposure to a "chloracno-
gen" before feeling comfortable classifying lesions as
chloracne. Still others may elect to perform a skin bi-
opsy to diagnose hyperkeratosis and atrophy of seba-
ceous glands microscopically before designatinga lesion
as chloracne. Other skin lesions, such as transient er-
ythema, may also arise from such exposure. This pro-
vides useful documentation ofexposure and sensitivity
to such chemicals; photographs ofsuch transient lesions
provide documentation afterwards.
Next, a careful examination ofthe eyes is indicated,
remembering the Yusho patients and their conjunctiv-
itis and discharge (14,15). Staining of gingiva may be
found after exposure to PCBs and furans, again as seen
in Yusho. Discolored skin and nails appears to predom-
inateinnewbornswheretherewastransplacentaltrans-
fer ofthese compounds from mother to baby while still
in utero.
Moving to the chest, careful evaluation of the lungs
is indicated. Serial pulmonary function tests might be
expected toreveal damage orlackofdamage fromthese
compoundsbetterthanauscultationandpercussion (10).
Wheezing or signs or symptoms ofedema might be noted
with an immediate allergic response, especially from
chemicals which might accompany the dioxins, furans
andPCBs. Apulmonaryfunctiontestmightberepeated
one and two years afterinitial exposure to detect latent
damage or recovery. One recalls the asbestos-induced
mesiotheliomas with peak incidence 30 to 40 years after
first exposure to asbestos (16). Possibly, repetition at
least once a year of major screening tests might be
indicateduntilmoremedicaldatabecomesavailable con-
cerning possible toxic effects of these chemicals alone
and in combination in humans. Pulmonary function ab-
normalities have been described in Yusho, as have ex-
cess pulmonary secretions.
Cardiacproblemsotherthanincreasedbloodpressure
(17) have not yet been described so only routine car-
diovascular evaluation ofheart and blood pressure seems
indicated. The increase in serum cholesterol and tri-
glycerides suggest a careful monitoring for atheroma-
tous blood vessel compromise considering especially
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coronary arteries, cerebral blood vessels and, possibly,
abdominal aorta.
Since renal infection and hemorrhage have been de-
scribed following dioxin exposure by Kimbrough and
others, careful attention to costovertebral angle tend-
erness is indicated. Levels of urinary uro- and copro-
porphyrins and their ratios should also be considered
(18) but are usually not abnormal after dioxin, chlori-
nated phenol, phenoxy herbicide or PCB exposure.
Because the liverhas been found to be atarget organ
for dioxin pathology in all species studied (19), careful
evaluation of the liver is important. The presence or
absence oftenderness or enlargement, as noted by pal-
pation and percussion, should be noted. Usually abdom-
inal findings are not remarkable but are of use in
establishing abaseline; one would notexpectimmediate
pathological findings since dioxins and PCBs are known
fortheirdelayed actioninmostanimalspecies. Theliver
can best be monitored by serum enzyme elevation and
liver biopsy with electron microscopic analysis oftissue
where relatively characteristic lesions occur after dioxin,
PCB, or Kepone exposure. Aryl hydroxyl hydroxylase
(AHH) or cytochrome P448 induction would be useful
to follow after exposure but there appears to be no
practical waytomonitorthis directlyinhumans atpres-
ent. Guzelian (3) has pointed out the pitfalls of relying
on enzyme levels alone and has also eloquently illus-
trated the value ofelectron microscopy when analyzing
liver needle biopsies (20). Without ultrastructural an-
alysis, important and possibly characteristic or path-
egnomoniclesionsmaybemissed. Therefore, whenliver
biopsies are taken, which may well be indicated after
dioxin exposure much more frequently than they are
done at present, ultrastructural evaluation is essential.
Alterations in liver ultrastructure, while similar with
many chlorinated comounds, may prove sensitive, al-
though these are not specific or pathognomonic lesions.
Continuing with the abdominal evaluation, palpation
and percussion ofthe spleen, to evaluate tenderness or
increase in size is theoretically indicated because ofthe
frequency ofinvolvement ofimmune, lymphatic, or re-
ticuloendothelial systems in multiple animal species (19).
However, the human literature is not replete with pos-
itive findings here either. It is not certain whether this
is because humans are less susceptible to the toxic ef-
fects of these drugs than the more susceptable animal
species or whether careful clinical evaluation has not
yet been carried out or reported after the now increas-
ingly frequent PCB exposures.
Continuing the physical examination, careful exami-
nation ofthe penis and also testes is indicated in males.
Penile abnormalities have been reported by Carnow in
a series of railroad workers in a recent court case (8).
Since etiology is important for legal as well as medical
reasons, careful recordingofany abnormalities existing
shortly after orideally, before, may be ofgreat medical
and legalusefulness. Again, because ofthese chemicals'
usual latency, penile deformity would not be expected
to be found immediately after such incidents. Exami-
nation of testes seems indicated because of the terato-
genetic properties of these compounds as well as the
atropic changes, necrosis and other pathological lesions
seen in various species of animals after exposure to
dioxins (19). Possible adverse reproductive outcome in
males exposed to dioxins in the absence of exposure of
the females has not been observed in animals. Agent
Orange, containing dioxins, is nevertheless suspected
by some (21) of causing fetal malformations and spon-
taneous abortions.
For similar reasons, thorough examination of the fe-
male reproductive system, including pelvic examina-
tion, Pap smear, and breast examination, seemsequally
indicated after exposure and periodically thereafter, on
the assumption that dioxins may well be cancer pro-
motingorinducingcompounds in humans and thatearly
detection ofcancers ofthe reproductive tract may well
lead to decreased mortality and morbidity.
Neurologial examination after dioxin exposure has
usually focussed on defects in peripheral nerve conduc-
tion velocity. Recently Schaumberg (22) has suggested,
because ofthe difficulty in standardizing peripheral nerve
conduction tests and because oftheir discomfort to pa-
tients, that peripheral nerve, e.g., finger, vibratory re-
sponse be the preferred test to detect early subtle
pathology in the peripheral nervous system caused by
toxic chemicals. This is a topic which occupational med-
icine physicians and neurologists will no doubt debate
for some time. In the meantime, careful documentation
ofpossible nervedamageisessential. Again, this should
be followed over time for at least one year, to detect
damage occurring after a latent period. Certainly, tox-
icityofrelatedcompounds, suchashexachloropheneand
its contaminants, to human brain is known, with brain
damage leading to death in some neonates washed in
hexachlorophene, and should alert the physician to per-
form a careful neurologic examination (23,24).
Careful attention should also be given to a careful
neuropsychiatric history because at this time the neu-
rotoxicologic and neurobehavioral characteristics of most
of these chemicals has not been established. It would
seem unwise at this time to dismiss complaints of anx-
iety, fatigue, irritability, inability to sleep, paranoia,
impotency, etc., out ofhand in patients exposed todiox-
ins and related compounds. Whether there is a direct
toxic effect or not on the central nervous system, there
may well be psychogenic pathology regardless ofmech-
anism of action which may lead to death, as was docu-
mented by the "successful" suicide ofajanitor involved
in the Binghamton State Office Building cleanup.
The endocrine system has not been systematically
considered in humans after exposure to dioxins, PCBs
and related chemicals. Adrenal cortical or medullary
changes may or may not occur. Thyroid and pituitary
hormone response has likewise not yet been the subject
of systematic observation in humans. Ordering specific
tests of endocrine function is not contraindicated, but
we have no standard protocols to follow at this time.
Attention should of course be paid to monitoring en-
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docrine abnormalities during physical examination as
well as by a careful medical history and by selected
laboratory testing.
Treatment of Patients
Careful monitoring of patients, by a physician and
nurse knowledgeable in the possible toxicology of the
chemicals involved and who are each trusted by the
patient and his or her family, is essential. This should
take place at least twice a year, preferably, briefly at
least, four times a year for the first few years after the
incident, because ofthe rapidly expanding state of our
knowledge regarding these chemicals, their possible very
toxic effects, the latency period characteristic of these
patients and the reassurance it may provide a patient
and family tohave the same knowledgeable, caringphy-
sician and nurse available over a period of years. This
surveillance shouldbelifelong, becauseofthepossibility
of cancer or other serious medical problems arising at
some future date. Classically in occupational medicine
it is common to illustrate the need for lifelong medical
surveillance, with its hope of reducing morbidity and
mortalitybyearlyintervention, byreferringtoasbestos
exposure, where peak mesothelioma rate occurs 30 to
40 years after first exposure. Even in the case ofearly
detection of those cancers for which there is currently
no effective treatment, this allows time for the family
involved to make social, legal and economic changes in
a timely fashion to diminish the impact of a premature
death on family members. In addition, early detection
may lead to cure. Cancers for which there are no cures
today, as, for example, certain of the soft tissues sar-
comas believed by some to be caused by dioxins (25),
may be curable in the future.
Reassurance may be provided to many patients be-
cause liver biopsies, fat biopsies or serum data may
suggest little or no exposure to toxic chemicals from a
givenincident. Byattemptingtoquantifyadditionalrisk
fromthese chemicals orcomparethisrisktoother, more
common risks, it is also possible to reassure some
patients.
Reproductive counseling would be another useful
function of the medical surveillance program. Certain
couples may wish to obtain information regarding the
possible adverse effect of PCBs or dioxins and furans
on reproductive outcome and plan future child bearing
accordingly. In a related matter, because PCBs and
related compounds concentrate in breast milk (as well
aspassthrough the humanplacenta) questions ofbreast
feeding by the exposed mother arise (26-29).
Unfortunately, we have no good advice to give nurs-
ing mothers regarding unsafe levels of PCBs in breast
milk. We also are not certain about the levels ofPCBs
found in substitutes for mothers milk. In addition we
have no data at this time regarding the presence of
chlorinated furans or dioxins in human breast milk, as
well as regarding their possible or presumed toxic ef-
fects on newborns. Yusho babies appear to have suf-
fered toxic effects, including low birth weight, discolored
skin and, in some cases death, from maternal PCB and
PCDF exposure.
One question the occupational medicine physician is
asked frequently by exposed workers and their families
is whether the compounds can be removed from the
body, especially if they are found by direct measure-
ment in fat or blood, or indirect measures of exposure
and sensitivity, such as elevated liver enzymes or skin
changes, etc., to be in the exposed worker.
In theory, the answer to this question is affirmative.
Nursing mothers certainly excrete PCBs and related
fatsolublechemicalsintheirmilk;presumablythiscould
be extended artificially long enough at least to deplete
PCB body burden in women. In addition we know from
work with chlordecone (Kepone) that one can remove
other related chlorinated aromatics from humans.
Starvation type diets were reported at the 1983 Na-
tional Institute on Environmental Health Sciences North
Carolina PCB meeting as being used in the Orient after
the Yu Cheng or Yusho incidents where PCBs and fur-
ans were consumed. Atthe 1983 Helsinki PCB meeting,
feeding ofcharcoal to PCB and PCDF exposed workers
in an attempt to eliminate some of the toxic chemicals
via feces was discussed by Jarvisalo, a Finnish occu-
pational medicine physician (30). At the present time
thereappearstobeno solidevidencethatthesemethods
are ofdemonstrated efficacy. Obviously that should not
preclude conducting tightly controlled clinical trials to
ascertain efficacy and potential side effects of special
diets, or feeding. Recently, a pharmaceutical product
was introduced for clinical testingin humans to attempt
to decrease body burden ofthese compounds. This pro-
tocol is currently under investigation in human clinical
trials.
It is important to recognize that the attending oc-
cupationalmedicinephysicianisconcerned notonlywith
the level ofexposure, as revealed by serum PCB levels
or adipose tissue dioxin and furan levels, and patterns
of isomers as well, but also the sensitivity of the body
to these compounds, as shown by elevated liver en-
zymes, abnormal liver hepatic parenchymal cell ultra-
structure, or rarely, by skin manifestations, including
skincancer, transienterythemaortherarelyseenchlor-
acne. Unfortunately at this time we have no sensitivity
testing to determine genetic predisposition to react to
these compounds. Even our most sensitive tests of ex-
posure, fat biopsies and serum levels, are not well de-
veloped at present. We do not know half lives,
metabolites, tissues ofdeposition, routes ofbodily elim-
ination to say nothing of toxicity for humans with re-
spect to the majority of polychlorinated dioxin, furan,
biphenylene, napthalene, biphenyl ethers or PCB iso-
mers in humans. Remembering the work of Brandt
(31,32), it is clear that various PCB isomers and me-
tabolites migrate to lung or kidney or liver or adipose
tissue. Fachetti's work (33) suggests 2,3,7,8-TCDD ac-
cumulates in highest concentration in adipose tissue,
then liver, and then other tissues at lesser amounts-
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at least in one patient who died of pancreatic cancer 5
months after initial exposure and who may therefore
not be typical. Rappe (34) and also Masuda (35-38) in
analysis of selected organs from human autopsy tissue
after exposure show that various PCB and furan iso-
mers may be found in differing amounts in different
organs. Hence, potential toxic effects may vary in a
qualitative and quantitative fashion depending on the
isomers involved. Thus careful, lifelong surveillance
seems indicated for exposed patients at this stage in
the evolution of our medical knowledge regarding the
effects of these chemicals in humans.
With the rapidly growing experience with human ex-
posure to dioxins, PCBs and furans, yearly reassess-
ment of appropriate medical surveillance is indicated.
New findings of high levels of dioxins and furans in
control patients as well as potentially exposed patients
suggests that a lesser degree ofmedical surveillance is
required ifthere is no evidence ofintake ofthese chem-
icals after an incident and a greater degree of surveil-
lance is recommended if there is evidence of increased
body burden (39,40).
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